Bristol Myers Squibb (BMS) has secured another win for Opdivo (nivolumab), becoming the only FDA-approved PD-1 inhibitor for resectable non-small cell lung cancer NSCLC in both a neoadjuvant-only ...

Bristol-Myers Squibb's Celgene unit has clearly been impressed by progress in its four-year-old alliance with Evotec on protein degradation. It's just paid $200 million to extend the partnership for ...

Mel Brooks has once again found himself at the center of controversy – this time for a new gag about Adolf Hitler that's been branded "offensive and out of touch" by critics, though the 99-year-old ...

Positive top-line results from the Phase III EMERGENT-4 and EMERGENT-5 open-label trials evaluating the long-term efficacy, safety, and tolerability of Cobenfy (xanomeline and trospium chloride) in ...

A desire to become the most dangerous criminal or the best cop that ever walked around any town has occurred to most people at least once in their lifetime. This game enables you to be both. You can ...